News Minimailist 11月04日 08:19
礼来减肥降糖药成为全球销量冠军
index_new5.html
../../../zaker_core/zaker_tpl_static/wap/tpl_guoji1.html

 

根据最新季度销售数据,礼来公司的糖尿病和肥胖症药物替尔泊肽(tirzepatide)已超越默克的癌症疗法Keytruda,成为全球销量第一的药物。礼来报告替尔泊肽第三季度销售额达101亿美元,而默克的免疫疗法Keytruda销售额为81亿美元。该药物的快速崛起凸显了市场对新型GLP-1类减肥疗法的强烈需求。基于强劲的业绩,礼来已上调了全年销售和收益预期。

📈 礼来公司生产的替尔泊肽(tirzepatide)药物,以其在减肥和糖尿病治疗方面的显著效果,在最新的季度销售报告中,销售额达到了101亿美元,成功超越了默克公司长期占据销售榜首的癌症药物Keytruda(销售额81亿美元),登顶全球最畅销药物的宝座。

🚀 替尔泊肽的强劲销售表现,直接反映了当前市场对于以GLP-1为基础的新型减肥治疗方案的巨大需求和高度关注,预示着这一类药物在未来医药市场中的重要地位。

📊 鉴于替尔泊肽的市场表现超出预期,礼来公司已对其全年的销售额和盈利预期进行了上调,显示出公司对该药物未来市场前景的乐观态度和战略信心。

In the last 4 days ChatGPT read 120105 top news stories. After removing previously covered events, there are 9 articles with a significance score over 5.9.

[6.2] Eli Lilly’s weight loss and diabetes drug becomes world’s best-selling medicine — statnews.com (+22)

Eli Lilly's diabetes and obesity drug, tirzepatide, has surpassed Merck's cancer therapy Keytruda to become the world's top-selling medicine based on the latest quarterly sales data.

Eli Lilly reported third-quarter sales of $10.1 billion for tirzepatide, which is sold as Mounjaro and Zepbound. This figure surpassed the $8.1 billion in sales reported by Merck for its immunotherapy drug, Keytruda.

The drug’s rapid rise highlights intense market demand for new GLP-1-based weight loss treatments. Following the strong results, Eli Lilly raised its full-year sales and earnings guidance.

[6.5] China and the US agree to ease chip export restrictions — bbc.com (+51)

China is easing its export ban on automotive computer chips as part of a new trade deal with the U.S., the White House announced following a leadership summit in South Korea.

The agreement, reached between Xi Jinping and Donald Trump, also covers U.S. soybean exports, rare earth minerals, and fentanyl materials, de-escalating the trade war started by U.S. tariffs this year.

The chip ban had raised concerns among automakers about potential production shutdowns. As part of the deal, China will also pause export controls on rare earth minerals for one year.

Highly covered news with significance over 5.5

[6.5] OpenAI partners with Amazon for $38 billion in AI computing power — apnews.com (+6)

[6.2] Google offers Gemini AI free to over 500 million Jio users in India — cnbc.com (+5)

[5.9] D66 wins Netherlands election, Rob Jetten to become prime minister — irishtimes.com (+58)

[5.8] India and the US sign a 10-year defense cooperation agreement — mathrubhumi.com (Malayalam) (+14)

[5.8] South Korea gains approval to build nuclear submarines in the US — dw.com (+9)

[5.8] US and China to establish direct military communication channels — asia.nikkei.com (+21)

[5.8] Victoria passes Australia's first formal treaty with Indigenous traditional owners — theguardian.com (+3)

Thanks for reading!

— Vadim


You can create your own personal newsletter like this with premium.

Fish AI Reader

Fish AI Reader

AI辅助创作,多种专业模板,深度分析,高质量内容生成。从观点提取到深度思考,FishAI为您提供全方位的创作支持。新版本引入自定义参数,让您的创作更加个性化和精准。

FishAI

FishAI

鱼阅,AI 时代的下一个智能信息助手,助你摆脱信息焦虑

联系邮箱 441953276@qq.com

相关标签

Eli Lilly tirzepatide weight loss drug diabetes drug best-selling medicine GLP-1 pharmaceuticals 礼来 替尔泊肽 减肥药 降糖药 全球销量 医药
相关文章